Considering that CD34 was used as hematopoietic stem cells (HSC) markers, the CD34+ LSCs were isolated from the bone marrow cells of CML patients and treated with compound DBH2 for 24 h. Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.